Market Overview The Treatment Resistant Depression Market is experiencing renewed scientific interest in psychedelic-assisted therapy as consciousness modulation demonstrates remarkable efficacy in treatment resistant depression clinical trials. The treatment resistant depression sector is projected to grow through 2030, driven by psilocybin FDA breakthrough therapy designation, MDMA-assisted...